Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines.
$0.76+10.15%
报价 2026-11-06
市值
$95M
EV
$67.1M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -74.1%
$0.64$2.95
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| MISTMilestone Pharmaceuticals Inc. | $95M | +10.2% | – | 94.6% | – | – | – | |
| NTHINeonc Technologies Holdings, Inc. | $100.5M | +9.1% | -100.0% | 0% | – | – | – | |
| BDTXBlack Diamond Therapeutics, Inc. | $99.4M | +4.5% | -89.9% | 0% | – | – | – | |
| UNCYUnicycive Therapeutics, Inc. | $97.2M | +2.0% | +3460.0% | 0% | – | – | – | |
| EQEquillium, Inc. | $95.7M | +13.5% | +41.8% | 0% | – | – | – | |
| NMRANeumora Therapeutics, Inc. Common Stock | $94.6M | +3.3% | – | 0% | – | – | – | |
| SEERSeer, Inc. | $90.3M | -4.1% | -4.1% | 47% | – | – | – | |
| CBUSCibus, Inc. | $90.2M | +3.5% | +90.0% | 72.1% | – | – | – | |
| ICCCImmuCell Corporation | $89M | -1.5% | 0.0% | 40.3% | 127.5x | 28.6x | 23.2x | |
| 同行中位数 | – | – | 0.0% | 0% | 127.5x | 28.6x | 23.2x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。